DR. E. SAMYN, huisarts
ActiveSummary
DR. E. SAMYN, huisarts has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €200k and a net result of €15k. Equity is growing by ~23.6% per year across the filed fiscal years. Its solvency ranks better than 25% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
69
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability60▼-2
Solvency62▲+5
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity short (current ratio 0.11 against 0.12 in 2023; short-term debt: 19.7% and cash: 0.5% of total assets), and 63.3% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 25% of 19908 sector peers (2024).
NBB · sector comparisonPosition among 19908 sector peers
Solvency
better than 25%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
28 d early
2022
38 d early
2021
37 d early
2020
52 d early
2019
53 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€200k▲ 8.4%
2023 · €185k
2018: €34k
2019: €66k
2020: €97k
2021: €127k
2022: €165k
2023: €185k
2018 → 2024
Total assets
€546k▼ 4.3%
2023 · €571k
2018: €626k
2019: €603k
2020: €591k
2021: €618k
2022: €605k
2023: €571k
2018 → 2024
Net result
€15k▼ 24.2%
2023 · €20k
2018: €11k
2019: €32k
2020: €31k
2021: €30k
2022: €37k
2023: €20k
2018 → 2024
Working capital
€-96k▼ 27.2%
2023 · €-76k
2018: €-46k
2019: €-45k
2020: €-45k
2021: €-63k
2022: €-61k
2023: €-76k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€97k-€127k▲ 30.8%€165k▲ 29.5%€185k▲ 12.4%€200k▲ 8.4%
Operating result€54k-€47k▼ 13.2%€64k▲ 36.0%€44k▼ 31.2%€38k▼ 14.2%
Net result€31k-€30k▼ 3.9%€37k▲ 25.2%€20k▼ 45.6%€15k▼ 24.2%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 14% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €546k
Fixed assets
€535k ▼ 4.6%
Current assets
€11k ▲ 12.3%
Equity and liabilities €546k
Equity
€200k ▲ 8.4%
Debt
€346k ▼ 10.4%
Debt's share of the balance-sheet total falls from 67.6% to 63.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€65k▼
2023 · €71k
Cash flow
€42k▼
2023 · €48k
Current ratio
0.11▼
2023 · 0.12
Debt to equity
1.73▼
2023 · 2.09
ROE
7.7%▼
2023 · 11.0%
ROA
2.8%▼
2023 · 3.6%
Interest coverage
4.54▼
2023 · 4.71
Debt ≤ 1 year
€108k▲
2023 · €86k
Debt > 1 year
€238k▼
2023 · €300k
Income taxes
€8k▼
2023 · €8k
Staff costs
€5k▼
2023 · €8k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 44 lines
Balance sheet
Code20232024
Assets
Total assets20/58€571k€546k▼
Fixed assets21/28€561k€535k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€559k€533k▼
Land and buildings22€523k€507k▼
Plant, machinery and equipment23€806€468▼
Furniture and vehicles24€35k€25k▼
Financial fixed assets28€2k€2k=
Current assets29/58€10k€11k▲
Amounts receivable within one year40/41€343€2k▲
Other amounts receivable41€343€2k▲
Cash at bank and in hand54/58€1k€3k▲
Deferred charges and accrued income490/1€9k€7k▼
Equity and liabilities
Total equity and liabilities10/49€571k€546k▼
Equity10/15€185k€200k▲
Contributions10/11€12k€12k=
Reserves13€173k€188k▲
Distributable reserves133€173k€188k▲
Amounts payable17/49€386k€346k▼
Amounts payable after more than one year17€300k€238k▼
Financial debts170/4€300k€238k▼
Amounts payable within one year42/48€86k€108k▲
Current portion of amounts payable after more than one year42€61k€62k▲
Trade debts44€2k€1k▼
Suppliers440/4€2k€1k▼
Taxes, remuneration and social security45€22k€31▼
Taxes450/3€2k-
Remuneration and social security454/9€20k€31▼
Other amounts payable47/48€950€44k▲
Income statement
Code20232024
Non-recurring operating income76A€2k-
Remuneration, social security and pensions62€8k€5k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€27k€27k▼
Other operating charges640/8€4k€5k▲
Gross operating margin9900€84k€74k▼
Operating profit (loss)9901€44k€38k▼
Financial charges65/66B€15k€14k▼
Recurring financial charges65€15k€14k▼
Profit (loss) for the period before taxes9903€29k€24k▼
Income taxes67/77€8k€8k▼
Profit (loss) for the period9904€20k€15k▼
Profit (loss) for the period to be appropriated9905€20k€15k▼
Appropriation of the result
Profit (loss) to be appropriated9906€20k€15k▼
Transfer to equity691/2€20k€15k▼
To other reserves6921€20k€15k▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200kEq €200k ▲8.4%
7 profitable years in a row build equity to €200k.
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
23-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2018net €37k ▲25.2%
Operating result €64k, net result €37k, both a record.
31-12
Financial
Equity above €150kEq €165k ▲29.5%
5 profitable years in a row build equity to €165k.
24-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Equity above €100kEq €127k ▲30.8%
4 profitable years in a row build equity to €127k.
09-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
08-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
24-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
19-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
06-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
30-05
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalst · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Langestraat 1129300 AalstGround area
1,617 m²
Building footprint
381 m²
Volume, LiDAR
1,036 m³
2 parcels, Flanders · tallest building 9.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. E. SAMYN, huisarts
since 20082.235.021.045
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41303D0433/00V000 | Flanders | 863 m² | 1 · 171 m² | 9.9 m · 2 fl. |
| 41304F0504/00K000 | Flanders | 754 m² | 1 · 210 m² | 6.0 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KANDIL HEALTH
BE 0810.308.108
Wavre · Eq €200,371
Coenen Bea Dr.
BE 0708.953.204
Antwerpen · Eq €200,459
DOKTER VERHAERT MICHIEL
BE 0749.875.722
Zonhoven · Eq €200,316
Dr. Katelijne Maus
BE 0792.959.855
Antwerpen · Eq €200,075
HUISARTS KATRIEN VERWILLIGEN
BE 0656.475.313
Gent · Eq €200,069
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,405 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-12-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.